Clinical Trial

RIDECLAS: Delphi Classification of RICA Pathway Recommendations

Study acronym: RIDECLAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.
Trial Details
NCT Number NCT07615855
Lead Sponsor Universidad de Zaragoza
Collaborators: Universidad Miguel Hernandez de Elche
Conditions Enhanced Recovery After Surgery, Perioperative Care, Surgical Care
Enrollment 384 participants
Start Date 2026-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29